AbbVie Inc. Equity-NMS: ABBV

Healthcare

Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$205.19
Open :$210.3
Today's high :$210.69
Today's low :$201.24
52W low :$149.557
52W high :$218.66
EPS(TTM): :2.39
Shares O/S :1.77 B
Market cap :356.47 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
AbbVie Inc. $201.51 -18.16% 85.85 356.47B

Frequently Asked Questions

What is the share price of AbbVie Inc. today?

AbbVie Inc. (ABBV) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About AbbVie Inc.

AbbVie Inc. is a global, diversified research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Its Immunology products include rheumatology, dermatology and gastroenterology. Its Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere, and Epkinly. The Company’s Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Its Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and Other eye care. Its Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its Venclexta is a B-cell lymphoma 2 (BCL-2) inhibitor used to treat blood cancers.